BiotechTube
Home/Nexalin Technology/Leslie Bernhard
LB

Leslie Bernhard

Chairman of the Board, Nominating & Corporate Governance Committee Chairman, Audit Committee Chairman, Compensation Committee

Nexalin Technology

Therapeutic Areas

NeurosciencePsychiatry

Nexalin Technology Pipeline

DrugIndicationPhase
Nexalin DeviceInsomniaPivotal Trial
NeuroCare® AI PlatformCare Delivery & ManagementLaunched

Leadership Team at Nexalin Technology

MW
Mark White
President and Chief Executive Officer, Board of Directors
DO
David Owens, M.D.
Chief Medical Officer, Board of Directors, Scientific Advisory Board
JV
Justin Van Fleet
Chief Financial Officer
CS
Carolyn Shelton
EVP of Clinical, Quality & Regulatory Affairs
JP
John Patrick Claude
Director of Engineering, Research and Development
AK
Alan Kazden
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee Chairman
BH
Benjamin Hu, M.D.
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee
View full Nexalin Technology profile